An exception is represented by MTAP deletion, that occurs in 11–14% and 28–33% of B-ALL [13, 14] and T-ALL [14, 15], respectively, and in 27.4% of cases from the pediatric B-ALL TARGET cohort (Fig. 2B). Here, MTAP is linked to acute lymphoblastic leukemia.